Filing Details

Accession Number:
0001209191-20-057717
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-10 17:42:25
Reporting Period:
2020-11-10
Accepted Time:
2020-11-10 17:42:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1623526 Stoke Therapeutics Inc. STOK Pharmaceutical Preparations (2834) 471144582
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780085 M. Huw Nash C/O Stoke Therapeutics, Inc.
45 Wiggins Avenue
Bedford MA 01730
Coo & Cbo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-10 36,586 $0.60 36,586 No 4 M Direct
Common Stock Acquisiton 2020-11-10 13,414 $2.19 50,000 No 4 M Direct
Common Stock Disposition 2020-11-10 50,000 $45.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2020-11-10 36,586 $0.00 36,586 $0.60
Common Stock Employee Stock Option (Right to Buy) Disposition 2020-11-10 13,414 $0.00 13,414 $2.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
222,371 2028-04-02 No 4 M Direct
136,797 2028-12-12 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The option vested as to 1/48th of the total shares on February 28, 2018, and then 1/48th of the total shares vest at the end of each month thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
  3. The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.